Drug Is First to Treat Cancer Based on Genetics, Not Location | #Research  | 21st Century Innovative Technologies and Developments as also discoveries, curiosity ( insolite)... | Scoop.it
From www.technologyreview.com - March 10, 2018 9:20 AM

Keytruda is the first that can be given to anyone who harbors one of two relatively rare genetic abnormalities, and is suffering from a solid tumor, such as pancreatic or lung cancer. Olivier Lesueur, managing partner at Bionest Partners, a consulting firm, calls the approval a “breakthrough in the way we see and define cancer.”

 

Keytruda works by unleashing the body’s immune system to attack tumors, and was first approved to treat advanced skin cancer in 2014. Such drugs, called checkpoint inhibitors, have had remarkable success, including saving the life of former U.S. President Jimmy Carter. The downside of immunotherapy is that not all patients seem to benefit, for reasons that remain uncertain.

 

Learn more / En savoir plus / Mehr erfahren:

 

https://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?&tag=Cancer